Want to see TSE:OGO full AI Analyst Report?
Organto Foods (OGO) AI Stock Analysis
Organto Foods
(TSXV:OGO)
The score is held back primarily by weak financial quality (ongoing losses and sustained negative operating/free cash flow) and bearish technicals (price below major moving averages with negative MACD). The earnings call provides a meaningful offset with strong sales momentum, improving gross profit, and recent EBITDA positivity, while valuation remains constrained by loss-making results and no dividend support.
Organto Foods (OGO) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 51.66M
- Dividend Yield
- ―
- Average Volume (3M)
- 43.95K
- Price to Earnings (P/E)
- -6.0
- Beta (1Y)
- 0.30
- Revenue Growth
- 96.04%
- EPS Growth
- 63.06%
- Country
- Canada
- Employees
- 40
- Sector
- General
- Sector Strength
- 55
- Industry
- Food Distribution
Organto Foods Business Overview & Revenue Model
Company Description
Organto Foods Inc. manages the complete lifecycle of organic and value-added fruit and vegetable products, from sourcing and processing to packaging, distribution, and market sale. Their diverse product portfolio includes a variety of organic fresh p...
How the Company Makes Money
Organto Foods makes money primarily by generating revenue from the sale of organic and non-GMO food products through business-to-business distribution and related commercial arrangements. Key revenue streams have included (1) distribution/wholesale s...
Organto Foods Earnings Call Summary
The call highlights a clear turnaround with record revenue, strong gross-profit growth, two consecutive EBITDA-positive quarters, improved liquidity and notable operational expansion (new customers, geographies, centers of excellence and digital investments). Challenges cited include modest margin levels despite improvement, volatility in fuel and shipping costs, absolute overhead growth due to scaling, supply/quality execution risk, and no near-term M&A closures despite an active pipeline. On balance, achievements and positive operational and financial momentum materially outweigh the challenges.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management's guidance emphasizes execution to convert first‑half momentum into sustainable, profitable growth by scaling the European Fresh platform, selectively pursuing M&A (including North America), adding higher‑margin/non‑fresh and value‑added products, and accelerating digital/AI efficiency. Key metrics cited: an annualized sales run‑rate above $100M (Q2 sales $27.7M, +61%; YTD $53.3M, +73%), Q2 gross profit $2.1M (7.5% of sales, +65%; YTD $3.9M, 7.3%), Q2 EBITDA $400k (1.5% of sales) and YTD EBITDA $500k (vs −$200k prior year), a target to drive cash overheads to just below 5% of sales (longer‑term under 5%, aiming ~4%), and a strong balance sheet (cash $5.4M + $1.0M restricted, working capital $15.3M, current assets $27.5M, no long‑term debt, equity $16.4M; Rabobank facility increased to €7M). Management expects continued EBITDA‑positive quarters but gave no specific numeric forward guidance beyond these targets.
Organto Foods Financial Statement Overview
Summary
Revenue is growing strongly, and the balance sheet is materially healthier with minimal debt and positive equity. However, profitability remains weak (net losses) and cash generation is a major issue with persistently negative operating and free cash flow, which meaningfully drags the financial score.
Income Statement
22NegativeBalance Sheet
58NeutralCash Flow
18Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Sep 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.31M | 60.84M | 20.70M | 27.68M | 22.12M | 19.52M |
| Gross Profit | 2.60M | 1.49M | 1.76M | 2.46M | 1.26M | 1.99M |
| EBITDA | -2.32M | -545.84K | -1.85M | -9.41M | -9.25M | -5.32M |
| Net Income | -9.47M | -16.82M | -4.54M | -13.43M | -10.83M | -6.34M |
Balance Sheet | ||||||
| Total Assets | 28.75M | 16.27M | 6.03M | 6.92M | 11.37M | 20.96M |
| Cash, Cash Equivalents and Short-Term Investments | 6.43M | 6.78M | 357.60K | 195.04K | 5.86M | 11.87M |
| Total Debt | 107.66K | 185.83K | 12.52M | 12.21M | 8.98M | 8.44M |
| Total Liabilities | 12.38M | 7.50M | 19.95M | 22.45M | 14.53M | 14.27M |
| Stockholders Equity | 16.38M | 8.77M | -13.91M | -15.54M | -3.16M | 6.69M |
Cash Flow | ||||||
| Free Cash Flow | -5.20M | -3.02M | -3.04M | -3.91M | -5.84M | -5.92M |
| Operating Cash Flow | -5.20M | -3.02M | -3.04M | -3.89M | -5.72M | -5.92M |
| Investing Cash Flow | 39.28K | -350.00K | -27.03K | -318.38K | -928.58K | -357.41K |
| Financing Cash Flow | 11.00M | 9.82M | 3.17M | -1.39M | -312.04K | 13.99M |
Organto Foods Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OGO, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.46, and below the 200-day MA of 0.71, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 36.83 is Neutral, neither overbought nor oversold. The STOCH value of 54.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:OGO.
Organto Foods Peers Comparison
Overall Rating
TSE:EBM53Neutral- TSE:OGO47Neutral
TSE:ZOG.X44Neutral
TSE:EWG42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TSE:EBM | 53Neutral | CAD 130.88M | -612.90 | 13.66% | ― | 36.59% | 43.33% |
| TSE:OGO | 47Neutral | CAD 51.66M | -6.00 | -76.61% | ― | 96.04% | 63.06% |
| TSE:ZOG.X | 44Neutral | CAD 491.47K | -6.62 | 290.24% | ― | ― | -29.09% |
| TSE:EWG | 42Neutral | CAD 13.40M | -3.00 | -210.36% | ― | -7.32% | 44.23% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:OGO | Organto Foods | 0.34 | -0.26 | -42.50% | |
| TSE:EBM | Eastwood Bio-Medical Canada | 1.90 | 1.25 | 192.31% | |
| TSE:EWG | Eat Well Investment Group Inc | 0.07 | -0.10 | -55.88% | |
| TSE:ZOG.X | Zoglo's Incredible Food Corp. | 0.03 | -0.01 | -33.33% | |
| TSE:FRSH | Fresh Factory B.C. Ltd. | 0.75 | -0.32 | -29.91% |
Organto Foods Corporate Events
Organato Foods Posts Record First-Half Results and Tops $100 Million Sales Run Rate
PositiveOrganto Foods reported record first-half 2026 sales of $53.3 million, up 73% year over year, alongside record adjusted gross profit and a swing to positive EBITDA. Management said the company has refocused its business, reorganized leadership and bro...
Organto Foods Targets Growth at Madrid’s Fruit Attraction 2026
PositiveOrganto Foods will participate in the Fruit Attraction 2026 trade show in Madrid from October 6 to 8, using the event to deepen relationships with retailers and suppliers and to pursue strategic partnerships. The company and its New Fruit Group subsi...
Organto Foods Delivers Record Q2 2026 Sales and EBITDA on Strong Organic Foods Growth
PositiveOrganto Foods reported record second-quarter 2026 results, with sales climbing 61% year over year to $27.7 million, the highest in its history, and gross profit rising 65% to $2.1 million, or 7.5% of sales. Adjusted gross profit, including currency h...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 21, 2026